How cardiovascular genetics and APOE ε4 status affect amyloid levels in early Alzheimer's disease
Official title: Cardiovascular Genotype and APOE ε4 Carrier Status Interaction Effects on Amyloid Load in Pre-Clinical Alzheimer's Disease
Funded at Banner Health · NIH-10849838 · Data updated 2026-11-12
This study is looking at how certain genes and the presence of the APOE ε4 gene might affect the buildup of amyloid plaques in people who are at risk for Alzheimer's disease, especially those with conditions like high cholesterol and high blood pressure, to see if there are ways to protect against Alzheimer's.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Banner Health NIH-funded |
| Lab location | 1 site (Phoenix, United States) |
| Project start | June 1, 2023 |
| Project end | March 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $89,442 |
| NIH project number | 5R03AG077270-02 |
| Project ID | NIH-10849838 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are older adults who are APOE ε4 carriers and may have cardiovascular risk factors.
✕Less likely to help
Patients who do not have pre-clinical Alzheimer's disease or are not APOE ε4 carriers may not benefit from this research.
What this research studies
This research investigates the interaction between cardiovascular genetic factors and APOE ε4 carrier status in relation to amyloid load in individuals with pre-clinical Alzheimer's disease. It aims to understand how conditions like high cholesterol and hypertension may influence the development of Alzheimer's pathology, particularly the formation of amyloid plaques. By analyzing specific genetic markers, the study seeks to uncover potential protective factors against amyloid deposition and their implications for Alzheimer's risk. Patients may undergo genetic testing and assessments to determine their eligibility and potential involvement in the research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and potential interventions for preventing or delaying Alzheimer's disease in at-risk individuals.
How similar studies have gone: Previous studies have shown promising results in understanding the relationship between cardiovascular health and Alzheimer's disease, suggesting that this approach may yield valuable insights.
Where this research is happening
-
Banner Health
Phoenix, United States Active
Researchers
- Principal investigator: Malek-Ahmadi, Michael — Banner Health
- Study coordinator: Malek-Ahmadi, Michael
Related research
Other NIH-funded projects on the same topics.
-
How adult children's education and economic situation affect parents' Alzheimer’s risk and outcomes
This project looks at whether adult children's education and financial resources affect older parents' chances of getting Alzheimer’s and how well parents do if they have dementia.
-
How adult children's socio-economic status affects their parents' risk of Alzheimer's disease.
This study looks at how the education and financial situation of adult children can affect the risk of Alzheimer's and related dementias in their aging parents, aiming to find ways to help keep older adults healthier based on their children's support.
-
Exploring how helping others may improve cognitive function and reduce Alzheimer's risk in older adults.
This study is looking at how helping others, like volunteering or lending a hand, can boost brain health in older adults, especially in African American communities, to see if these good deeds might help prevent or slow down Alzheimer's Disease.
-
The link between early life blood sugar levels and Alzheimer's disease markers in middle age.
This study is looking at how blood sugar levels in early life might affect brain health and the risk of Alzheimer's disease later on, and it's for middle-aged people who want to understand how their early life health could impact their memory and thinking in the future.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.